Jdoryson t1_j0jy0gy wrote
Forgive me please for not being impressed with a sample size of 20 (bivalent boosted) being the data set used to draw the major conclusion.
But this is what I expect from the CDC these days... Confirmation bias and cherry picked data.
Ghosted19 t1_j0ktche wrote
Well I guess the public beta tests will change your mind. In all seriousness, 20?! That’s not enough to create accurate data. In my line of work we make high tolerance low volume parts….to try to assess our CPK based on PPM is impossible due to the skew one failed dimension would put on the rest of the analysis. I cannot see how extrapolation of data from 20 samples could accurately gage anything.
[deleted] t1_j0mdkaz wrote
[removed]
Optimal-Spring-9785 t1_j0qa2vt wrote
Because there are hundreds of other subjects in this early release study
[deleted] t1_j0mfu2r wrote
[removed]
[deleted] t1_j0mvhc1 wrote
[removed]
sethbr t1_j0nrbzp wrote
In the actual study, 79 had received the bivalent booster.
Viewing a single comment thread. View all comments